Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Whiteley, L. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteley, L. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Colonic Mucosal Aberrant Crypt Foci: Are They Useful Intermediate Endpoints for Predicting and Understanding the Development of Colonic Mucosal Neoplasia?

Laurence O. Whiteley

Human and Environmental Safety Department Miami Valley Laboratories The Procter & Gamble Co. Cincinnati, Ohio 45253-8707

References

  • Bjerknes M. and Cheng H. (1999). Colossal crypts bordering colon adenomas in APCMIN mice express full-length Apc. Am. J. Pathol. 154: 1831-1834.[Abstract/Free Full Text]
  • Cameron IL, Garza J., and Hardman WE (1996). Distribution of lymphoid nodules, aberrant crypt foci and tumours in the colon of carcinogen-treated rats. Br. J. Cancer 73: 893-898.[Web of Science][Medline] [Order article via Infotrieve]
  • Chang WL, Chapkin RS, and Lupton JR (1997). Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18: 721-730.[Abstract/Free Full Text]
  • Deschner EE (1974). Experimentally induced cancer of the colon. Cancer 34: 824-828.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Deschner EE and Maskens AP (1982). Significance of the labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals. Cancer 50: 1136-1141.[CrossRef][Medline] [Order article via Infotrieve]
  • Fearon ER and Vogelstein B. (1990). A genetic model of colorectal tumorigenesis. Cell 61: 759-767.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Food and Drug Administration ( 1997). Proposed Rule: Food Labeling: Health Claims; Soluble fiber from certain foods and coronary heart disease. Fed. Reg. 62: 28234.
  • Green SE, Chapman P., Bum J., Burt AD, Bennett M., Appleton DR, Varma JS, and Mathers JC (1998). Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer. Gut 43: 85-92.[Abstract/Free Full Text]
  • Goodlad RA, Ratcliffe B., Lee CY, and Wright NA (1995). Dietary fiber and the gastrointestinal tract: Differing trophic effects on muscle and mucosa of the stomach, small intestine and colon. Eur. J. Clin. Nutr. 49(suppl 3): S178-S181.[Web of Science][Medline] [Order article via Infotrieve]
  • Isaacson P. and Atwood J. (1979). Failure to demonstrate specificity of the morphological and histochemical changes in the mucosa adjacent to colonic carcinoma (transitional mucosa). J. Clin. Pathol. 32: 214-218.[Abstract/Free Full Text]
  • Jacoby RF, Marshell DJ, Moser AR, and Dove WF (1996). Chemoprevention spontaneous intestinal adenomas in the ApcMIN mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56: 710-714.[Abstract/Free Full Text]
  • Jass JR (1998). Diagnosis of hereditary non-polyposis colorectal cancer. Histopathology 32: 491-497.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jass JR, Jioka Y., Redojkovic MR, Allison LJ, and Lane MR (1997). Failure to detect colonic mucosal hyperproliferation in mutation positive members of a family with hereditary non-polyposis cancer. Histopathology 30: 201-207.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kinzler KW and Vogelstein B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lipkin M. (1988). Biomarkers of increased susceptibility of gastrointestinal cancer: New application to studies of cancer prevention in human subjects. Cancer Res. 48: 235-245.[Free Full Text]
  • McShane LM, Kulldorff M., Wargovich MJ, Woods C., Purewal M., Moler J., and Schatzkin A. (1998). An evaluation of rectal mucosal proliferation measure variability sources in the Polyp Prevention Trial: Can we detect informative differences among individuals' proliferation measures amid the noise? Cancer Epidemiol. Biomark Prev. 7: 605-612.[Abstract]
  • Magnuson BA and Bird RP (1993). Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid. Cancer Lett. 68: 15-23.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Moen Cja, Van der Valk MA, Bird RP, Hart Aam, and Demant P. (1996). Different genetic susceptibility to aberrant crypt and colon adenomas in mice. Cancer Res. 56: 2382-2386.[Abstract/Free Full Text]
  • Oshima H., Oshima M., and Taketo MM (1997). Morphologic and molecular processes of polyp formation in Apc knockout mice. Cancer Res. 57: 1644-1649.[Abstract/Free Full Text]
  • Steele VE, Moon RC, Lubet, RA, Boone CW, and Kelloff GJ (1994). Preclinical efficacy evaluation of potential chemopreventative agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program. J. Cell Biochem. Suppl. 20: 32-54.
  • Takahashi S., Ogawa K., Ohshima H., Esumi H., Ito N., and Sugimura T. (1991). Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazol-pyridine. Jpn. J. Cancer Res. 82: 135-137.[CrossRef][Web of Science]
  • Wargovich MJ, Hams C., Chen C., Palmer C., Steele VE, and Kelloff GJ (1992). Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J. Cell Biochem. Suppl. 16C: 51-54.
  • Whiteley LO, Anver MR, Botts S., and Jokinen MP (1996). Proliferative lesions of the intestine, salivary glands, oral cavity and esophagus in rats. In: Guides for Toxicologic Pathology. STP/ARP/ AFIP, Washington, D.C.
  • Whiteley LO, Higgins JM, Purdon MP, Ridder GM, and Bertram TA (1996). Evaluation in rats of the dose-response relationship among colonic mucosal growth, colonic fermentation, and dietary fiber. Dig. Dis. Sci. 41: 1458-1467.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Whiteley LO, Hudson L., and Pretlow TP (1996). Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol. Pathol. 24: 681-689.[Abstract/Free Full Text]
  • Whiteley LO and Klurfeld DM (2000). Are dietary fiber-induced alterations in colonic epithelial cell proliferation predictive of fiber's effect on colon cancer? Nutr. Cancer (in press).
  • Whiteley LO, Purdon MP, Ridder GM, and Bertram TA (1996). The interactions of diet and colonic microflora in regulating colonic mucosal growth. Toxicol. Pathol. 24: 305-314.[Abstract/Free Full Text]
  • Wilcox DK, Higgins J., and Bertram TA (1992). Colonic epithelial cell proliferation in a rat model of nongenotoxin-induced colonic neoplasia. Lab. Invest. 67: 405-411.[Web of Science][Medline] [Order article via Infotrieve]
  • Zheng Y., Kramer PM, Lubet RA, Steele VE, Kelloff GJ, and Pereira MA (1999). Effect of retinoids on AOM-induced colon cancer in rats: Modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 20: 255-260.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 27, No. 6, 643-644 (1999)
DOI: 10.1177/019262339902700605


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Whiteley, L. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteley, L. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?